GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genincode GENI.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.60p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Genincode — daily GENI

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Genincode on TradingView ↗
Market value
£1.7m
Last close × shares
Volume
2.1m
Shares, 9 Nov 2026

About Genincode

Its shares trade on LSE under the ticker GENI.L. It has been listed since 22 July 2021. In the fiscal year to 31 December 2025, it reported revenue of £3.1m and a net loss of £5.7m. At that date it held total assets of £2.4m and shareholders' equity of £124,000.

GENinCode Plc engages in the genetic risk assessment of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm is engaged in the risk assessment, prediction, and prevention of cardiovascular disease (CVD). Its tests include Cardio Incode, Lipid Incode, Sudd Incode, Roca Test, Thrombo and Thrombo Incode Reproductive Health. The firm's product portfolio draws on advanced genomic precision testing using polygenic (multiple genes) technology, molecular testing, genotyping, sequencing, and AI bioinformatics to risk assess patient DNA. Its predictive technology provides patients and physicians with global preventative care and treatment strategies. Its products combine genetic and clinical data to risk-assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. The Company’s wholly owned subsidiaries include GENinCode S.L.U. and GENinCode U.S. INC.

Figures and description from our data supplier, not checked against the company's own report.

More about Genincode →

Latest on Genincode

Our reporting

We have not reported on Genincode yet.

Next results

8 Jun 2027

Due on 8 Jun 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Genincode's ticker?

Genincode trades as GENI.L on LSE, under ISIN GB00BL97B504.

What was Genincode's last closing price?

0.60p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Genincode next report results?

Results are expected on 8 Jun 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.